ArticleEuropean journal of drug metabolism and pharmacokinetics2025

Simulated Dosing Regimens of Subcutaneous Infliximab in Adults and Children with Inflammatory Bowel Disease: Exploring Switch and Initiation Strategies.

Rianne A Weersink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.